Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-05

Clinical Trial Update: Plasmodium Falciparum Clearance Rates in Response to Artesunate in Eastern Cambodia

View source ↗

Summary

The update reports Plasmodium falciparum clearance rates following artesunate treatment in eastern Cambodia. The study is sponsored by NIAID and focuses on mala…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artesunate (artesunate)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Malaria | Status: COMPLETED